Both RLS (increased expression of bcl-2) and RLS-40 (overexpression of mdr1a/mdr1b genes) lymphosarcoma cells showing different types of drug resistance were less susceptible to the virus than KB-3-1 and B-16 cells. This evidence concerns the gene BCL2 and lymphoma.